Announcements Trials

Browse Landscape

Phase

Status

Sponsor Class

Study Type

Interventional 1

Sponsor

Cancer Type

Conditions

Breast Neoplasms 12 Triple Negative Breast Neoplasms 2 Neoplasms 1 Lymphedema 1 Breast Cancer Invasive 1 Anatomic Stage II Breast Cancer AJCC v8 1

Interventions

pyrotinib 1 pertuzumab 1 Trastuzumab 1 Surgical Procedures, Operative 1 Mastectomy 1 130-nm albumin-bound paclitaxel 1

Date Range

30 days 90 days 1 year All

Options

Has results Has announcements

Clinical Trials

1 trials

Recent Start date Enrollment

Phase 2 × Breast Cancer Invasive × Mastectomy × Clear all

NCT03627988 2026-05-22

MARTA

Institut Claudius Regaud

Phase 2 Completed

Breast Cancer Invasive

Data powered by HemOnc (CC BY 4.0) Colophon ⚡